title: Biomarkers and response to bevacizumab--response.
authors.affiliation: Authors' Affiliations: Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds; St James's Institute of Oncology, Bexley Wing; Cancer Research UK Centre, Leeds Institute of Molecular Medicine, St James's University Hospital; Department of Clinical Biochemistry and Immunology, Leeds General Infirmary, Leeds; MRC Clinical Trials Unit; UCL Cancer Institute, University College, London; and Christie Hospital, University of Manchester, Withington, Manchester, United Kingdom.
authors.forename: Fiona
authors.initials: F
authors.lastname: Collinson
authors.forename: Michelle
authors.initials: M
authors.lastname: Hutchinson
authors.forename: Rachel A
authors.initials: RA
authors.lastname: Craven
authors.forename: David A
authors.initials: DA
authors.lastname: Cairns
authors.forename: Zougman
authors.initials: Z
authors.lastname: Alexandre
authors.forename: Tobias C
authors.initials: TC
authors.lastname: Wind
authors.forename: Narinder
authors.initials: N
authors.lastname: Gahir
authors.forename: Michael P
authors.initials: MP
authors.lastname: Messenger
authors.forename: Sharon
authors.initials: S
authors.lastname: Jackson
authors.forename: Douglas
authors.initials: D
authors.lastname: Thompson
authors.forename: Cybil
authors.initials: C
authors.lastname: Adusei
authors.forename: Jonathan
authors.initials: J
authors.lastname: Ledermann
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Hall
authors.forename: Gordon C
authors.initials: GC
authors.lastname: Jayson
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Selby
authors.forename: Rosamonde E
authors.initials: RE
authors.lastname: Banks
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D005185:Fallopian Tube Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood*; D018579:Patient Selection; D010534:Peritoneal Neoplasms / Q000097:blood*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D014408:Biomarkers, Tumor